NMS Company
Seminari di Oncologia
Seminari di Oncologia
Nerviano Medical Sciences organizza una serie di Seminari di Oncoloiga, dove regolarmente i relatori sono invitati a presentare le ultime scoperte.
Solitamente gli argomenti dei seminari sono tesi ad una migliore comprensione del processo tumorale e alla possibile applicazione della ricerca e tecnologia attuali al fine di scoprire e sviluppare innovativi farmaci per la cura del cancro.
Riportiamo di seguito i prossimi eventi.
Per partecipare può contattare il seguente numero: 0331-5814 67/78.
- 15 maggio 2009 (1:30-2:30 PM)
Jacques Poussyégur
Institute of Signaling, Developmental Biology and Cancer Research, CNRS
Centre A. Lacassagne, Nice, France - 13 marzo 2009 (1:30-2:30 PM)
Niels Mailand
Dept. of Cell Cycle and Cancer Danish Cancer Society
Strandboulevarden 49,Copenhagen O,Denmark - 20 febbraio 2009 (13:30-14:30)
Salvatore Siena
Director of The Falck Division of Medical Oncology Ospedale Niguarda Ca' Granda
Piazza Ospedale Maggiore 3, Milano - 6 febbraio 2009
Stefan Knapp
Principal Investigator Phosphorylation Dependent Signaling Group,Structural Genomics Consortium (SGC)
Oxford, UK - 30 gennaio 2009 (1:30-2:30 PM)
NAD(P): much more than basic metabolism. From signal transduction to cancer therapy
Armando Genazzani
Dip. di Scienze chimiche, Alimentari, Farmaceutiche e Farmacologiche
Università degli Studi del Piemonte Orientale, Novara - 16 gennaio 2009 (1:30-2:30)
Nuove terapie per le malattie mieloproliferative croniche
Alessandro Rambaldi
Direttore del reparto di Ematologia-Ospedali riuniti di Bergamo
Bergamo
ARCHIVIO:
Archivio 2006
- 12 dicembre 2006 (2:00 PM)
Francesco Senigaglia
Bioxell, Segrate, Italy - 5 dicembre 2006 (2:00 PM)
Giorgio Inghirami
CeRMS, University of Turin - 28 novembre 2006 (2:00 PM)
Multi diversity generation reactions as tools for exploring molecular diversity
Luca Banfi
Dip. Chmica e Chimica Industriale, Università di Genova
Genova - Italy - 31 ottobre 2006 (2:00 PM)
Modified Carbohydrates as tools in Medicinal Chemistry
Francesco Nicotra
Università di Milano Bicocca
Milan - Italy - 10 ottobre 2006 (2:00 PM)
Pathogenesis of hereditary disorders defective in nucleotide-excision repair: from clinical features to molecular defects
Miria Stefanini
Istituto di Genetica Molecolare CNR Pavia - 26 settembre 2006 (2:00 PM)
Functional interplay between chromatin structure and DNA damage processing in the control of genome stability
Paolo Plevani
Università degli Studi di Milano
Milano - Italy - 4 luglio 2006 (2:00 PM)
Molecular imaging and nuclear medicine: a research program in oncology
Guido Biasco, Cristina Nanni, Maria Pantaleo
University of Bologna
Bologna - Italy - 27 giugno 2006 (2:00 PM)
Use of PNAs in the study and for possible therapy of Lymphomas
Manlio Ferrarini
Istituto Nazionale per la Ricerca sul Cancro, IST
Genova - Italy - 13 giugno 2006 (2:00 PM)
Positron Emission Tomography (PET) as Biomarker in Drug Development
Piero Salvadori
CNR Institute of Clinical Physiology
Pisa - Italy - 23 maggio 2006 (2:00 PM)
The challenge of Biomarkers for Novel Mechanism-Based Anticancer Therapies
Caroline Dive
University of Manchester and Christie Hospital NHS Trust Withington
Manchester - U.K. - 16 maggio 2006 (2:00 PM)
Changing Paradigms in Drug Discovery
Hugo Kubinyi
Weisenheim am Sand
Germany - 9 maggio 2006 (2:00 PM)
Molecular mechanisms of melanoma development and progression
Anja Bosserhoff
Universität Regensburg
Germany - 2 maggio 2006 (2:00 PM)
Mitotic Checkpoint Kinases in Chromosome Instability and Cancer
Geert Kops
UMC Utrecht
The Netherlands - 21 marzo 2006 (2:00 PM)
Loco-regional treatments: state of art and future perspective
Luigi Solbiati
General Hospital
Busto Arsizio (Varese) - Italy - 7 marzo 2006 (2:00 PM)
New approaches for a selective treatment of cancer based on the antibody-directed enzyme prodrug therapy
Lutz Tietze
University of Goettingen
Goettingen - Germany - 28 febbraio 2006 (3:00 PM)
Defects in mismatch repair, processing of DNA damage and genetic instability
Margherita Bignami
Istituto Superiore di Sanità
Roma - 21 febbraio 2006 (2:30 PM)
Molecular basis of Philadelphia-negative chronic myeloproliferative disorders
Mario Cazzola
University of Pavia Medical School
Pavia - Italy - 14 febbraio 2006 (2:00 PM)
Planning and Conduct of Phase I Trials in Oncology
Luca Gianni
Istituto Nazionale per la Cura e lo Studio dei Tumori
Milano - Italy - 17 gennaio 2006 (2:00 PM)
Finding targets of transcription factors in vivo by "ChIP on chip" analysis
Roberto Mantovani
University of Milano
Milano - Italy
Archivio 2007
- 18 dicembre 2007 (2-3 PM)
Giovanni Gaudino
University of Piemonte orientale “A.Avogadro”
Novara - 4 dicembre 2007 (2 PM)
Oncology Exploration - panning for gold in biomolecular space
David Lloyd
School of Biochemistry and Immunology Trinity College
Trinity College Dublin, Dublin 2, Ireland
Email: lloyddg@tcd.ie - 23 novembre 2007 (2,30-3,30 PM)
The mitochondrial regulation of cell death and its possible therapeutic implications
Sten Orrenius
Institute of Environmental Medicine,Division of Toxicology- Karolinska Institutet
Stockholm, Sweden - 6 novembre 2007 (2-3 PM)
Molecular targeted therapie of cronic myelogeneus leukemia
Tim Bruemmendorf
Klinik für Onkologie/Hämatologie
Hamburg - 16 ottobre 2007 (2-3 PM)
"New approaches for virtual screening"
Giulio Rastelli
Dipartimento di Scienze Farmaceutiche Facolta' di Bioscienze e Biotecnologie Universita' di Modena e Reggio Emilia - 9 ottobre 2007 (2-3 PM)
Computational tools to predict chemical properties, with emphasis on toxicity and endocrine disruption".
Emilio Benfenati
Laboratory of Environmental Chemistry and Toxicology, istituto di Ricerche Farmacologiche "Mario Negri"
via La Masa 19, Milano
Email: benfenati@marionegri.it - 2 ottobre 2007 (2-3 PM)
Post-translational modifications in disease pathogenesis: examples from proteomic studies on a neurodegenerative disorder
Valentina Bonetto
Istituto di Ricerche Farmacologiche "Mario Negri", Milano,Italy
Email: bonetto@marionegri.it - 25 settembre 2007 (2-3 PM)
Inflammation and cancer: from biology to target validation
Alberto Mantovani
Istituto Clinico Humanitas
Milan, italy - 11 settembre 2007 (2-3 PM)
Prognostic and therapeutic implications of cancer stem cells from solid tumors
Ruggero De Maria
Istituto Superiore di Sanità-Roma - 4 settembre 2007 (2,30-3,30 PM)
Integrins, mediators and therapeutic targets of tumor angiogenesis and metastasis
Curzio Ruegg
CePO and ISREC
Epalinges, Switserland - 17 luglio 2007 (2-3 PM)
A quantitative analysis of the cell cycle molecular regulatory network
Andrea Ciliberto
Computational Cell Biology, IFOM
Via Adamello 16 I-20141 Milan, Italy - 19 giugno 2007 (2-3 PM)
Therapeutic monoclonal antibodies in oncohematology:factors affecting efficacy
Josee Golay
Division of Hematology, Ospedali Riuniti, Bergamo,Italy - 19 giugno 2007 (2-3 PM)
Josee Golay and Martino Introna
Laboratory of Cellular and Gene Therapy "G. Lanzani" - 22 maggio 2007 (11-12 AM)
Translational Research Unit, Unit 10 Department of Experimental Oncology and Laboratories
Maria Grazia Daidone
Istituto Nazionale per lo Studio e la Cura dei Tumori
Via Venezian, 1, 20133 Milan, Italy - 15 maggio 2007 (2- 3 PM)
Gian Cesare Tron
Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center Universita degli Studi del Piemonte Orientale A. Avogadro
Via Bovio 6, 28100 Novara, Italy
Email: tron@pharm.unipmn.it - 10 aprile 2007 (2:00 PM)
Reazioni stereoselettive promosse da catalizzatori organici e organometallici
Maurizio Benaglia
University of Milano - 3 aprile 2007 (2 - 3 PM)
Deoxynucleoside kinases as tools in drug discovery and therapy monitoring
Staffan Eriksson
Department of Anatomy, Physiology and Biochemistry The Swedish University of Agricultural Sciences, BMC - 27 marzo 2007 (2 - 3 PM)
Sensing and responding to DNA damage
Noel Lowndes
Genome Stability Laboratory Department of Biochemistry and National Centre for Biomedical Engineering Science National University of Ireland Galway, Ireland - 13 marzo 2007 (2 - 3 PM)
Impact of biocatalysis on the quality of pharmaceutical ingredients
Marco Terreni
Pharmaceutical Biocatalysis Laboratories Università degli Studi di Pavia and INNOVATE BIOTECHNOLOGY S.r.l. - 6 marzo 2007 (2:00 PM)
Pro-apoptotic activity of NBDHEX, a suicide inhibitor of glutathione transferases
Anna Maria Caccuri
University of Rome "Tor Vergata", Rome - 27 febbraio 2007 (2:00 PM)
Angiogenesis and the tumor microenvironment as target fot therapy and cancer prevention
Adriana Albini
IRCCS Multimedica, Milano - 13 febbraio 2007 (2:00 PM)
Enrico Marcantoni
University of Camerino, Camerino, Italy - 6 febbraio 2007 (2:00 PM)
Thomas Carell
Ludwig-Maximilians University, München, Germany - 30 gennaio 2007 (2:00 PM)
Federico Bussolino
IRCC, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy
Archivio 2008
- 19 dicembre 2008 (1:30-2:30 )
Maurizio Pellecchia
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
North Torrey Pines. Rd., La Jolla, CA - 12 dicembre 2008 (13:30-14:30 PM)
Ulrich Pfeffer
National Cancer Research Institute
Genova, Italy - 21 novembre 2008 (1:30-2:30 PM)
David Parker
Department of Chemistry
Durham University, UK - 14 novembre 2008 (1:30-2:30PM)
Prof Mauro Magnani
Istituto di Chimica Biologica "G. Fornaini",Università degli Studi "Carlo Bo"
Urbino - 7 novembre 2008
The CD38/NAD+/Cyclic ADP-ribose/intracellular calcium signalling pathway: mechanisms and therapeutic outlook
Antonio De Flora
Department of Experimental Medicine Center of Excellence for Biomedical Research of Genova
Genova - 24 ottobre 2008 (1:30-2:30 PM)
From Mad Cow Disease to Sepsis: how NMR can help
Luigi Calzolai
Medway School of Pharmacy, Universities of Kent and Greenwich at Medway
Chatham Maritime,Kent - 17 ottobre 2008 (10:00-11:00 )
T-cell gene manipulation by chimeric TcR for innovative treatment of acute leukemia
Andrea Biondi
Dipartimento di Medicina Clinica e Prevenzione Direttore, Centro Ricerca M. Tettamanti
Monza (Italy) - 10 ottobre 2008 (1:30-2:30 PM)
Boudewijn Lelieveldt
Division of Image Processing,Department of Radiology,Leiden University Medical Center
Leiden, The Netherlands - 26 settembre 2008 (1:30-2:30PM)
Cancer mutations and targeted therapies
Alberto Bardelli
Laboratory of Molecular Genetics-The Oncogenomics Center, Institute for Cancer Research and Treatment (IRCC)
Candiolo (Torino) - 12 settembre 2008 (1:30-2:30 PM)
Leucemia acuta mieloide con mutazione della nucleophosmina:aspetti biologici e clinici
Brunangelo Falini
Institute of Hematology University of Perugia
Perugia - 5 settembre 2008 (1:30-2:30PM)
The petidyl prolyl isomerase Pin1 is a novel pharmacological target in cancer therapy: enhanced responses of acute myeloid leukemia cells to retinoids
Enrico Garattini
Laboratory of Molecular Biology,Istituto di Ricerche Farmacologiche "Mario Negri"
Via La Masa, 19 Milano - 18 luglio 2008 (1:30-2:30 PM)
Mode and dynamics of protein-DNA interactions at a human replication origin
Arturo Falaschi
Professore di Biologia Molecolare Scuola Normale Superiore
Pisa - 4 luglio 2008 (1:30- 2:30 PM)
Mutations of NPM in Acute Myeloid Leukemia
Emanuela Colombo
IFOM-IEO
Milano - 27 giugno 2008 (11:30-12:30 PM)
Therapeutic potential of cancer stem cells from solid tumors
Ruggero De Maria
Isituo Superiore Sanità
Roma - 20 giugno 2008 (1:30-2:30 PM)
Polyamines: old molecules, new syntheses, new opportunities. The multicomponent reactions protagonist in the medicinal chemistry
Gian Cesare Tron
Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center
Università Studi del Piemonte Orientale A. Avogadro-Novara - 30 maggio 2008 (1:30-2:30 PM)
CDC25 phosphatases. Cell cycle regulators and therapeutic targets
Bernard Ducommun
Institut d'Exploration Fonctionnelle des Génomes
Toulouse - 23 maggio 2008 (1:30- 2:30 PM)
Targeting breast cancer: from the benchside to the bed and vice versa
Giancarlo Pruneri
Division of Pathology and Laboratory Medicine European Institute of Oncology
Milano - 16 maggio 2008 (1:30-2:30 PM )
The role of the human mismatch repair system in drug resistance
Josef Jiricny
Institute of Molecular Cancer Research,University of Zürich
Zürich - 9 maggio 2008 (1:30-2:30 PM)
Vascuar tumor targeting: from the bench to the clinic
Dario Neri
Institute of Pharmaceutical Sciences
Swiss Federal Institute of Technology, Zurich - 2 aprile 2008 (2:30-3:30 PM)
The ubiquitin-dependent chaperone VCP/p97/Cdc48 regulates Aurora-B activity on mitotic chromatin
Hemmo Meyer
ETH Swiss Federal Institute of Technology
Zurich - 1 febbraio 2008 (1:30- 2:30 PM)
Cancer mortality trends in the European Union: priorities for cancer control
Carlo La Vecchia
Head, Laboratory of General Epidemiology,Istituto di Ricerche Farmacologiche "Mario Negri"
Milano
© Nerviano Medical Sciences